POINT Biopharma Global In... (PNT)

AI Score

Unlock

12.50

0.02 (0.16%)

At close: Dec 26, 2023, 9:00 PM

POINT Biopharma Global Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Revenue	2.79M	4.87M	9.46M	226.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	-9.45B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	168.31K	n/a
Gross Profit	2.79M	4.87M	9.46B	226.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-168.31K	n/a
Operating Income	-29.63M	-31.5M	-22.46M	191.36M	-24.64M	-24.89M	-16.31M	-14.1M	-17.03M	-8.65M	-5.73M	-5.4M	-3.08M	-3.23M
Interest Income	n/a	n/a	n/a	n/a	n/a	509.7K	47.97K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-23.9M	-26.33M	-16.77M	194.11M	-23.83M	-24.4M	-16.29M	-14.14M	-17.04M	-8.68M	-5.74M	-5.54M	-3.05M	-3.13M
Net Income	-24.77M	-25.41M	-16.53M	163.27M	-24.01M	-24.58M	-16.38M	-14.2M	-17.12M	-8.8M	-5.78M	-5.55M	-3.05M	-3.19M
Selling & General & Admin	5.51M	5.09M	5.01M	7.28M	3.84M	4.08M	3.81M	4.57M	4.03M	1.95M	1.46M	1.29M	596.16K	1.07M
Research & Development	26.91M	31.28M	26.91M	27.94M	20.8M	20.81M	12.5M	9.53M	13M	6.7M	4.27M	4.12M	2.48M	2.16M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	32.42M	36.36M	31.92M	35.22M	24.64M	24.89M	16.31M	14.1M	17.03M	8.65M	5.73M	5.4M	3.08M	3.23M
Interest Expense	n/a	n/a	n/a	n/a	1.05M	509.7K	47.97K	40.25K	6.18K	2.86K	2.8K	2.85K	2.51K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	32.42M	36.36M	31.92M	35.22M	24.64M	24.89M	16.31M	14.1M	17.03M	8.65M	5.73M	5.4M	3.08M	3.23M
Income Tax Expense	871.45K	-921.3K	-238.64K	30.84M	180.5K	183.41K	88.12K	60.41K	81.04K	123.78K	40.42K	14.38K	n/a	58.26K
Shares Outstanding (Basic)	105.77M	105.72M	105.66M	96.03M	92.4M	90.12M	90.12M	90.12M	90.12M	57.58M	56.67M	17M	54.18M	90.12M
Shares Outstanding (Diluted)	105.77M	105.72M	105.66M	96.03M	92.4M	90.12M	90.12M	90.12M	90.12M	57.58M	56.67M	17M	54.18M	90.12M
EPS (Basic)	-0.23	-0.24	-0.16	1.73	-0.26	-0.27	-0.18	-0.16	-0.19	-0.15	-0.1	-0.33	-0.06	-0.04
EPS (Diluted)	-0.23	-0.24	-0.16	1.70	-0.26	-0.27	-0.18	-0.16	-0.19	-0.15	-0.1	-0.33	-0.06	-0.04
EBITDA	-34.49M	-35.88M	-27.62M	191.89M	-24M	-24.52M	-16.05M	-14.1M	-17.03M	-8.65M	-5.73M	-5.4M	-3.08M	-3.23M
EBIT	n/a	n/a	-6.19B	193.69M	-22.78M	-23.89M	-16.24M	n/a	-17.03M	-8.68M	-5.74M	-5.53M	-3.04M	n/a
Depreciation & Amortization	863.92K	784.7K	-5.16M	531.87K	640.71K	372.1K	255.88K	-40.25K	54K	55.81K	55.21K	55.13K	3.21M	51.12K